A patient with knee osteoarthritis or a partial rotator cuff tear arrives at your site after reading a dozen overpromised stem cell pages. They want to know if leukocyte-rich PRP actually helps a 55-year-old with bone-on-bone medial compartment knee OA, what bone marrow aspirate concentrate (BMAC) costs out of pocket, whether adipose-derived stromal vascular fraction is FDA-cleared (it largely is not), and how the clinic's pricing of $1,500 to $4,500 per injection compares to the $20,000 packages selling elsewhere. Honest practices lose calls every day to clinics with shinier marketing and weaker evidence.

SleekAI maps your orthobiologic catalog (leukocyte-rich PRP, leukocyte-poor PRP, BMAC, lipoaspirate, hyaluronic acid plus PRP combinations, autologous protein solution), evidence summaries, candidacy rules, and the procedures that are out of scope (homologous use stem cell products from third parties, fetal or amniotic injections marketed as live stem cells). Pull cash_price, evidence_level, typical_response_rate, injection_count, and fda_status from postmeta on your therapy posts. The bot tells a visitor that a single leukocyte-rich PRP for knee OA is $850, that two to three injections at 4 to 6 week intervals are the typical protocol, and that the published response rate for moderate OA is around 50 to 70%.

Generic bots overpromise stem cell magic, ignore FDA constraints around minimal manipulation and same-day use, and quote prices that drive sticker shock without context. They cannot read your group's honest evidence summaries or know your candidacy rules. SleekAI grounds every answer in the live WordPress fields you maintain, so the bot stays inside your scope, your evidence statements, and your protocols. Honest regenerative practices need this more than anyone.

Regenerative medicine is the most misrepresented field in orthopedic medicine. A 2018 FDA enforcement action targeted dozens of clinics for marketing unapproved cultured stem cell products, and the misinformation has only grown since. Patients are caught between honest clinics quoting realistic 50-70% response rates and predatory clinics promising $20,000 stem cell cures.

The honest clinic that explains the evidence plainly, names the FDA status accurately, and quotes a transparent $850 PRP price wins the trust battle in the first conversation. The bot is also a triage tool. Many patients who think they want PRP are actually surgical candidates with bone-on-bone arthritis and severe deformity.

A bot that screens them in 30 seconds and routes them to a surgical consult saves the patient $1,700 and saves the clinic a confused, dissatisfied review. The transcripts are a marketing goldmine. They show which competing clinic prices patients quote, which fake stem cell products they have been told about, and which evidence questions they actually have.

That feedback loop tightens the content on the site and trains the front desk on the questions patients are really asking. The regenerative clinics that win the next decade will be the ones whose marketing matches their evidence. A working chatbot is the cheapest way to put that integrity in front of every visitor.